triazoles has been researched along with Dizzyness in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, Y; Iwakura, M; Maeda, Y; Miyazaki, M; Sano, H; Takeuchi, Y | 1 |
| Dehghani, A; Dehghani-Tafti, M; Karimi Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S | 1 |
| Alsaad, AM; Koren, G | 1 |
| Brittain, C; Foster, J; Jackson, K; McColm, J; Soon, D; Suriyapperuma, S; Swanson, S; Tauscher-Wisniewski, S | 1 |
| Krishna, G; Moton, A; Wang, Z | 1 |
| FLETCHER, R | 1 |
| Diener, HC; Lines, CR; McCarroll, KA; Silberstein, SD | 1 |
| Johnson, JR; Kelly, R; Mann, BS; Pazdur, R; Sridhara, R; Williams, G | 1 |
| Lader, MH | 1 |
| Blum, RA; Brucker, MJ; Ermlich, SJ; Goldberg, MR; Lee, Y; McLoughlin, DA; Olah, TV; Rogers, JD; Sterrett, AT; Zhao, J | 1 |
| Brewer, ER; Carson, SW; Golding, M; Kotlyar, M | 1 |
| Baggen, S; Cohen, AF; Fuseau, E; Pereira, A; Pieters, MS; Schoemaker, RC; Schram, MT; van der Post, J; van Gerven, JM | 1 |
3 review(s) available for triazoles and Dizzyness
| Article | Year |
|---|---|
Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials.
Topics: Anticonvulsants; Central Nervous System Diseases; Disorders of Excessive Somnolence; Dizziness; Drug Resistance; Epilepsy; Fatigue; Headache; Humans; Randomized Controlled Trials as Topic; Risk; Triazoles | 2014 |
Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers.
Topics: Adolescent; Aged; Animals; Antifungal Agents; Clinical Trials, Phase I as Topic; Dizziness; Dose-Response Relationship, Drug; Electrocardiography; Female; Headache; Humans; Liver Function Tests; Male; Middle Aged; Triazoles; Xerostomia; Young Adult | 2009 |
Tolerability and safety: essentials in antidepressant pharmacotherapy.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depressive Disorder; Dizziness; Drug Overdose; Humans; Incidence; Nausea; Patient Dropouts; Piperazines; Placebos; Sleep; Treatment Outcome; Triazoles; Xerostomia | 1996 |
4 trial(s) available for triazoles and Dizzyness
| Article | Year |
|---|---|
Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Curettage; Dizziness; Endometrial Hyperplasia; Estradiol; Female; Fertility Preservation; Headache; Humans; Letrozole; Medroxyprogesterone Acetate; Middle Aged; Nitriles; Triazoles; Young Adult | 2013 |
Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Bridged Bicyclo Compounds; Cohort Studies; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Half-Life; Headache; Healthy Volunteers; Humans; Male; Middle Aged; Nausea; Placebos; Prodrugs; Receptors, Metabotropic Glutamate; Triazoles; Vomiting; Young Adult | 2017 |
Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Dizziness; Female; Humans; Injections, Intravenous; Migraine Disorders; Serotonin Receptor Agonists; Tachycardia; Triazoles; Tryptamines | 1998 |
CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephalography; Eye Movements; Female; Headache; Humans; Hypnotics and Sedatives; Nerve Tissue Proteins; Neuropsychological Tests; Postural Balance; Reaction Time; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recognition, Psychology; Reference Values; Serotonin Receptor Agonists; Sumatriptan; Temazepam; Triazoles; Tryptamines | 2002 |
5 other study(ies) available for triazoles and Dizzyness
| Article | Year |
|---|---|
Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan.
Topics: Aged; Azepines; Dizziness; Female; Humans; Japan; Male; Middle Aged; Product Surveillance, Postmarketing; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Triazoles | 2020 |
Postural vertigo and positional nystagmus.
Topics: Animals; Brain; Dizziness; Eye; Gastropoda; Head; Humans; Male; Nystagmus, Pathologic; Nystagmus, Physiologic; Orthotic Devices; Physical Therapy Modalities; Posture; Triazoles; Vertigo; Vestibular Function Tests | 1952 |
CNS effects of sumatriptan and rizatriptan.
Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephalography; Eye Movements; Female; Headache; Humans; Hypnotics and Sedatives; Nerve Tissue Proteins; Neuropsychological Tests; Postural Balance; Reaction Time; Recognition, Psychology; Serotonin Receptor Agonists; Sumatriptan; Temazepam; Triazoles; Tryptamines | 2004 |
Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Approval; Female; Follow-Up Studies; Headache; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Skin Diseases; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; United States; United States Food and Drug Administration | 2005 |
Possible nefazodone withdrawal syndrome.
Topics: Adult; Dizziness; Humans; Male; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles | 1999 |